Manara - Qatar Research Repository
Browse
1/1
2 files

Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR): clinical heterogeneity and long-term efficacious management of eight patients from four unrelated Arab families with a loss of function VDR mutation

Version 3 2023-10-11, 09:34
Version 2 2023-10-04, 09:45
Version 1 2023-07-13, 06:09
journal contribution
revised on 2023-10-11, 09:33 and posted on 2023-10-11, 09:34 authored by Muhammad Faiyaz-Ul-Haque, Waheeb AlDhalaan, Abdullah AlAshwal, Bassam S. Bin-Abbas, Afaf Alsagheir, Maram AlOtaiby, Zulqurnain Rafiq, Syed H.E. Zaidi

Background

Vitamin D regulates the concentrations of calcium and phosphate in blood and promotes the growth and remodeling of bones. The circulating active form of vitamin D, 1,25-dihydroxyvitamin D, binds to the vitamin D receptor (VDR), which heterodimerizes with the retinoid X receptor to regulate the expression of target genes. Inactivating mutations in the VDR gene cause hereditary vitamin D-resistant rickets (HVDRR), a rare disorder characterized by an early onset of rickets, growth retardation, skeletal deformities, hypocalcemia, hypophosphatemia and secondary hyperparathyroidism, and in some cases alopecia.

Methods

We describe eight new HVDRR patients from four unrelated consanguineous families. The VDR gene was sequenced to identify mutations. The management of patients over a period of up to 11 years following the initial diagnosis is assessed.

Results

Although all patients exhibit main features of HVDRR and carry the same c.885C>A (p.Y295*) loss of function mutation in the VDR gene, there was heterogeneity of the manifestations of HVDRR-associated phenotypes and developmental milestones. These eight patients were successfully treated over a period of 11 years. All clinical symptoms were improved except alopecia.

Conclusions

The study concludes that VDR sequencing and laboratory tests are essential to confirm HVDRR and to assess the effectiveness of the treatment.

Other information

Published in: Journal of Pediatric Endocrinology and Metabolism
License: http://creativecommons.org/licenses/by/4.0
See article on publisher's website: http://dx.doi.org/10.1515/jpem-2017-0312

Funding

Open Access funding provided by the Qatar National Library

History

Language

  • English

Publisher

De Gruyter

Publication Year

  • 2018

License statement

This Item is licensed under the Creative Commons Attribution 4.0 International License

Institution affiliated with

  • Hamad Medical Corporation
  • Hamad General Hospital - HMC

Usage metrics

    Hamad Medical Corporation

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC